SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-045588 from Boxabl Inc. (CIK 0001816937)

Boxabl Inc. (CIK 0001816937)
Date: Dec. 20, 2023 · CIK: 0001816937 · Accession: 0001493152-23-045588

AI Filing Summary & Sentiment

File numbers found in text: 000-56579

Referenced dates: December 18, 2023

Date
December 8, 2023
Author
/s/
Form
CORRESP
Company
Boxabl Inc. (CIK 0001816937)

Letter

Office of Real Estate and Construction Division of Corporation Finance Securities and Exchange Commission Amendment No. 3 to Registration Statement on Form 10-12G Filed December 8, 2023 File No. 000-56579

Re: Boxabl Inc.

Dear Ms. Breslin:

We acknowledge receipt of the comments in your letter dated December 18, 2023, regarding Amendment No. 3 to the Registration Statement on Form 10-12G of Boxabl Inc. (the “Company”), which we have set out below, together with our responses. All responses below refer to revised disclosure in Amendment No. 4 to our Form 10-12G filed simultaneously with the submission of this correspondence.

Amendment No. 3 to Registration Statement on Form 10-12G /A filed December 8, 2023

Item 2. Financial Information, page 25

1. We note your response to prior comment 6; however, you have not provided a more detailed discussion regarding the company’s quality and regulatory issues referenced within your results of operations discussion on page 26 or a discussion about whether the permitting process delay was a one-time event or may continue in the future and affect future revenues. Please revise.

Please see the revised disclosure on pages 25 and 26.

2. We note your response to prior comment 7. Please revise your disclosure to include the expected sources of funds for the costs estimated for the first three months and provide estimates and sources for the work contemplated for months three through 12 in your planned timeline.

Please see the revised disclosure to “Planned Timeline” and the related disclosure immediately below the table on page 37.

Item 15. Financial Statements and Exhibits

Note 2 -Summary of Significant Accounting Policies

Marketable Securities, page F-41

3. We note the disclosure you added regarding your investments on pages F-7 and F-41. The language used in the disclosure does not appear to agree with the language used in your financial statements. Please address the following:

● Revise to clarify if your marketable securities include long-term and short-term investments in U.S. Treasury Notes, as noted in the Consolidated Balance Sheets presented.

● Revise to state the name of the account in the Consolidated Statements of Operations for both the year ending December 31, 2022 and the period ending September 30, 2023 where you report both realized and unrealized gains and losses on all investments. In your disclosures you state these gains and losses are recognized in “investment and other income (expense);” but these account names are not presented in your financial statements.

Please see the revised disclosure in:

● Note 1 – Basis of Presentation to the Consolidated Financial Statements for the nine months ended September 30, 2023 and 2022 located on page F-7;

● Revised name of account to “Interest, Unrealized Gains and Other Investment Income” in the Consolidated Statement of Operations for the three and nine months ended September 30, 2023 and 2022 on page F-3, and in the Consolidated Statement of Operations for the three and six months ended June 30, 2023 and 2022 on page F-19;

● Note 3 – Investments to the Consolidated Financial Statements for the nine months ended September 30, 2023 and 2022 located on page F-12 and to the Consolidated Financial Statements for the Years Ended December 31, 2022 and 2021 located on page F-46;

● Note 3 – Summary of Significant Accounting Policies – Cash and Cash Equivalents to the Consolidated Financial Statements for the six months ended June 30, 2023 and 2022 located on page F-24;

● Note 4 – Investments to the Consolidated Financial Statements for the six months ended June 30, 2023 and 2022 located on page F-28; and

● Note 2 – Summary of Significant Accounting Policies to the Consolidated Financial Statements for the Years Ended December 31, 2022 and 2021 located on page F-41.

Thank you again for the opportunity to respond to your questions regarding the Offering Statement of Boxabl Inc. If you have additional questions or comments, please contact me at andrew@crowdchecklaw.com.

Sincerely,
/s/
Andrew Stephenson

Show Raw Text
CORRESP
1
filename1.htm

December
20, 2023

Ms.
Mary Beth Breslin

Legal
Branch Chief

Office
of Real Estate and Construction

Division
of Corporation Finance

Securities
and Exchange Commission

Washington
DC 20549

    Re:
    Boxabl
    Inc.

Amendment
No. 3 to Registration Statement on Form 10-12G

Filed
December 8, 2023

File
No. 000-56579

Dear
Ms. Breslin:

We
acknowledge receipt of the comments in your letter dated December 18, 2023, regarding Amendment No. 3 to the Registration Statement on
Form 10-12G of Boxabl Inc. (the “Company”), which we have set out below, together with our responses. All responses below
refer to revised disclosure in Amendment No. 4 to our Form 10-12G filed simultaneously with the submission of this correspondence.

Amendment
No. 3 to Registration Statement on Form 10-12G /A filed December 8, 2023

Item
2. Financial Information, page 25

1.
We note your response to prior comment 6; however, you have not provided a more detailed discussion regarding the company’s quality
and regulatory issues referenced within your results of operations discussion on page 26 or a discussion about whether the permitting
process delay was a one-time event or may continue in the future and affect future revenues. Please revise.

Please
see the revised disclosure on pages 25 and 26.

2.
We note your response to prior comment 7. Please revise your disclosure to include the expected sources of funds for the costs estimated
for the first three months and provide estimates and sources for the work contemplated for months three through 12 in your planned timeline.

Please
see the revised disclosure to “Planned Timeline” and the related disclosure immediately below the table on page 37.

Item
15. Financial Statements and Exhibits

Note
2 -Summary of Significant Accounting Policies

Marketable
Securities, page F-41

3.
We note the disclosure you added regarding your investments on pages F-7 and F-41. The language used in the disclosure does not appear
to agree with the language used in your financial statements. Please address the following:

    ●
    Revise
    to clarify if your marketable securities include long-term and short-term investments in U.S. Treasury Notes, as noted in the Consolidated
    Balance Sheets presented.

    ●
    Revise
    to state the name of the account in the Consolidated Statements of Operations for both the year ending December 31, 2022 and the
    period ending September 30, 2023 where you report both realized and unrealized gains and losses on all investments. In your disclosures
    you state these gains and losses are recognized in “investment and other income (expense);” but these account names are
    not presented in your financial statements.

Please
see the revised disclosure in:

    ●
    Note
    1 – Basis of Presentation to the Consolidated Financial Statements for the nine months ended September 30, 2023 and 2022 located
    on page F-7;

    ●
    Revised
                                            name of account to “Interest, Unrealized Gains and Other Investment Income” in
                                            the Consolidated Statement of Operations for the three and nine months ended September 30,
                                            2023 and 2022 on page F-3, and in the Consolidated Statement of Operations for the three
                                            and six months ended June 30, 2023 and 2022 on page F-19;

    ●
    Note
    3 – Investments to the Consolidated Financial Statements for the nine months ended September 30, 2023 and 2022 located on page
    F-12 and to the Consolidated Financial Statements for the Years Ended December 31, 2022 and 2021 located on page F-46;

    ●
    Note
    3 – Summary of Significant Accounting Policies – Cash and Cash Equivalents to the Consolidated Financial Statements for
    the six months ended June 30, 2023 and 2022 located on page F-24;

    ●
    Note
    4 – Investments to the Consolidated Financial Statements for the six months ended June 30, 2023 and 2022 located on page F-28;
    and

    ●
    Note
    2 – Summary of Significant Accounting Policies to the Consolidated Financial Statements for the Years Ended December 31, 2022
    and 2021 located on page F-41.

Thank
you again for the opportunity to respond to your questions regarding the Offering Statement of Boxabl Inc. If you have additional questions
or comments, please contact me at andrew@crowdchecklaw.com.

    Sincerely,

    /s/
    Andrew Stephenson

    Andrew
    Stephenson

    Partner

    CrowdCheck
    Law LLP

    cc:
    Paolo
    Tiramani

    Chief
    Executive Officer

    Boxabl
    Inc.